Samir Mehta is building Torrent Pharma through a string of acquisitions

Mehta is silently working on plans to offset risks through acquisitions and entry into new geographies

At 52, Samir Mehta, the vice-chairman of the $2.9-billion Torrent Group and chairman of Torrent Pharma, is focused on his goal. After taking full charge of Torrent three years ago, Mehta has not only made it to the fifth spot on the most valued CEOs list of 2017 but has also pulled off three acquisitions. Torrent is all set to make its second acquisition this year and the biggest since its Elder Pharma deal in December 2013 — Unichem's domestic formulations business. 

Mehta became the chairman of Torrent Pharma in May 2014. 

Mehta has been instrumental in identifying new opportunities